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Faecal specimens were collected from infants and children with common infections who presented to the Paediatrics 
Outpatient Department of the National Children's Hospital, San Jose, Costa Rica or to the Paediatrics Clinic, Texas 
Tech University Health Sciences Center, Lubbock, Texas. Specimens were obtained before administration of various 
antibiotics, 7 d after therapy was begun and 28 d after completion of treatment. The antibiotics prescribed were 
either amoxicillin, ampicillirt, cephalexin, choramphenicol, dicloxocillin, erythromycin, penicillin or trimethroprim/ 
sulphamethoxazole. Faecal concentrations of total and individual volatile fatty acids (VFA) and faecal pH levels were 
determined and compared before, during and after treatment with the various antibiotics. Specimens, collected during 
the same time periods from a group of healthy infants and children who were not taking antibiotics, were evaluated to 
determine if normal fluctuations occurred between samplings. There were no significant differences in the Texas 
subjects in total VFA concentrations and pH levels between the patients receiving antibiotics and healthy participants 
who did not. With the exception of erythromycin administered to Costa Rican patients, therapeutic doses of the 
antibiotics did not significantly alter total VFA concentrations or pH levels of the faeces. Variations in concentrations 
of individual VFAs as a consequence of treatment were demonstrated only in Costa Rican patients teceiving either 
erythromycin or cephalexin; however, the patterns of change were similar to those observed in untreated control 
participants from Texas and were therefore not attibuted to antibiotic administration. These results are in accordance 
with our previous studies which show that absorbable antibiotics, administered to mice in therapeutic doses, do not 
significantly alter total VFA concentrations or pH levels of caecal contents and do not increase the susceptibility of the 
animals to oral challenge with enteric pathogens.' We speculate that the use of absorbable antibiotics does not 
compromise natural resistance against infections of the intestinal tract of humans. 
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INTRODUCTION 
Acute diarrhoea is an important childhood illness 
because of its high prevalence and the high associ-
ated mortality, especially in developing countries.16 
Several reports indicate that the risk of diarrhoea 
caused by enteric pathogens increases when humans 
and animals are treated with antibiotics.5•6• 7•18'" 
There is evidence from animal studies that the 
administration of antibiotics increases suscepti-
bility to colonisation with a variety of enteric 
pathogens including Vibrio cholerae, - Salmonella 
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enteritidis, Pseudomonas aeruginosa, and Shigella 
flexneri.'.2' 8' 11' 17 The increased susceptibility is 
thought to result from disruption of the indigenous 
intestinal flora, producing conditions that favour 
multiplication of enteric pathogens. 
The mechanisms by which the indigenous intesti-
nal flora provide protection against colonisation by 
enteric pathogens are not completely understood., 
but there is compelling evidence that short chain 
volatile fatty acids (VFA) generated by flora com-
ponents as metabolic end-prodncts play a critical 
role.3.4•14 Studies in our laboratory have demon-
strated that the VFA, in concentrations found in 
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caeca! contents of conventional mice, inhibit the 
multiplication of P. aertiginosa, Salmonella 
typhimurium, S. flexneri and enterotoxigenic 
Escherichia coli in vitro.9.13' 17 The organisms multi-
plied however in the presence of VFA in concen-
trations observed in the contents of streptomycin 
treated mice.' Streptomycin, when administered to 
mice in high doses, significantly lowers caeca' VFA 
concentrations and increases intraluminal pH levels 
and reduces colonisation resistance to challenge 
with enteric pathogens."." However, orogastric 
administration of amoxicillin, erythromycin, chlor-
amphenicol and trimethoprim/sulphamethoxazole 
to juvenile mice in doses identical on a weight basis 
to those given to infants and children in the present 
study, neither significantly lowered caeca] VFA con-
centrations, nor increased caecal pH levels.10 When 
these mice were challenged, susceptibility to colon-
isation with enteric pathogens apparently was not 
increased. 
The purpose of this study was to determine if oral 
administration of antibiotics to infants and children 
to treat a variety of infections influenced faecal pH 
levels and VFA concentrations in the same manner. 
MATERIALS AND METHODS 
Study population 
Infants and children under 5 y of age who pre-
sented to the Paediatric Outpatient Department 
of the National Children's Hospital, the Social 
Security Trust, San Jose, Costa Rica, or to the 
Paediatric Clinic, Texas Tech University Health 
Sciences Center, Lubbock, Texas, with common 
infections (otitis media, streptococcal pharyngitis, 
impetigo and sinusitis) were enrolled in this study. 
Patients who had been treated with antibiotics 
within a month preceding the visit or whose main 
complaint was suggestive of an acute enteric 
infection were excluded. 
Design of study 
After the patients with the acute minor infections 
were evaluated, antibiotics were prescribed. The 
choice of antibiotics depended on availability, the 
specific illness and the prescribing preference of the 
participating physicians. The different antibiotic 
preparations studied reflected a variety of classes 
including some widely prescribed in the US and 
Costa Rica and some available over the counter, 
without a prescription, in developing countries. 
Amoxicillin at 40 mg/kg/day, trimethoprim/  
sulphamethoxazole (TMS) at 10 mg/kg/day of the 
trimethoprim component, erythromycin ethylsucci-
nate 40 mg/kg/day or penicillin V potassium at 
25 mg/kg/day were administered at the Texas Tech 
University Clinic. Ampicillin trihydrate at 70 mg/ 
kg/day, cephalexin at 40 mg/kg/day, dicloxacillin at 
25 mg/kg/day, erythromycin stearate at 40 mg/kg/ 
day, chloramphenicol palmitate at 50 mg/kg/day or 
trimethoprim/sulphamethoxazole (TMS) at 10 mg/ 
kg/day of the trimethoprim component were 
administered in Costa Rica. 
Faecal specimens were collected from the patients 
before antibiotic administration, 7 d after therapy 
was begun and 28 d after completion of treatment. 
Hospital specimens were collected by a technician; 
post-antibiotic specimens were collected either by 
the mother, an attendant or by a technician. Speci-
mens were placed in screw capped containers that 
were tightly closed and refrigerated until they were 
collected. Although patients from Texas or Costa 
Rica served as their own controls, specimens from 
healthy children who were not treated with anti-
biotics collected over a similar time period were 
included, in order to measure normal variations of 
faecal VFA concentrations and pH levels and to 
determine if these factors differ in healthy and 
infected infants and children. 
Measurement of pH and VFA concentration in faeces 
Immediately after arrival at the laboratory, both 
in Lubbock and San Jose, the pH values of faecal 
specimens were determined potentiometrically, and 
the specimens then frozen at — 70°C. Faecal speci-
mens from Costa Rica were shipped to Lubbock 
by air express in sealed containers packed with dry 
ice. All specimens were thawed and 1 g of each 
homogenised with 1 ml of distilled water. The 
homogenates were acidified with 0.1 ml/g of 50 per 
cent H2SO4 and 1 ml of anhydrous ethyl ether 
added to extract short-chain VFA. The ether-faecal 
content homogenate was mixed in a culture tube by 
inverting the tube 20 times and venting occasionally 
to release the pressure. The mixture was centri-
fuged at 2500 rpm using an IEC clinical centrifuge 
(International Equipment Co., Needham Heights, 
MA) for 10 min to break the emulsion and the tubes 
placed in a — 70°C freezer until the aqueous phase 
froze. The ether extract was then injected onto 
the column of a gas chromatograph containing a 
thermal conductivity detector (series 550; Gow-
Mac Instruments Co., Bridgewater, N.J.). The 
chromograph was equipped with two stainless steel 
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columns (182.9 by 0.32 cm) packed with 10 per cent 
SP-1000 plus I per cent H3PO4 on Chromosorb 
WAW (100/120 mesh). The flow rate of helium, the 
carrier gas, was 120 ml/min. The injection port tem-
perature was 175°C, the column 145°C and detector 
155°C. Peaks of VFA were identified and quantified 
by reference to different concentrations of VFA 
standards. VFA concentrations were reported as 
micro-equivalents per gram wet weight of faeces. 
Statistical analysis 
Statistical evaluations of the significance of dif-
ferences in pH levels and VFA concentrations were 
performed using the Fisher's least significant 
difference and the Duncan Neuman-Keul tests. 
RESULTS 
A total of 117 of the 126 initial participants com-
pleted the study, 48 in Texas and 69 in Costa Rica. 
In Lubbock 11 participants served as healthy, 
untreated comparison patients, 13 patients received 
amoxicillin, 14 received erythromycin ethylsucci-
nate, seven received TMS and three received 
penicillin. In Costa Rica, 14 patients received ampi-
cillin trihydrate, 11 received dicloxocillin, 13 
received cephalexin, 14 received TMS, I I received 
erythromycin stearate and six received chloram-
phenicol palmitate. Three faecal samples were 
obtained from all of the enrolled participants 
before, during and after treatment. Of the nine 
patients who did not complete the study, some were 
lost to follow up while others, who required a 
change in antibiotic during therapy due to either 
treatment failure or adverse reactions to an 
antibiotic therapy, were excluded from analysis. 
Total faecal VFA concentrations of healthy, 
untreated comparison patients in Texas and corre-
sponding patients with infections were not signifi-
cantly different, nor were there differences in total 
VFA concentrations between patients from Texas 
and patients from Costa Rica. Although there were 
fluctuations in the concentrations of total VFA of 
specimens from both Texas and Costa Rica col-
lected before, during or after treatment, these did 
not follow consistent patterns and were not signifi-
cantly different from the concentrations measured 
in specimens from the healthy participants. Among 
the Texas patients, there were no statistically sig-
nificant changes in total faecal VFA concentrations 
attributable to antibiotic use (Table 1). A significant  
decrease in total faecal VFA was observed, on the 
other hand, when Costa Rican patients were given 
erythromyin. Among the untreated participants in 
Texas, the specimens obtained during the second 
sampling period contained significantly greater 
total VFA than specimens obtained during the third 
sampling period indicating fluctuations of VFA do 
occur over time, which may reflect diet or other 
factors. 
When individual VFA were considered, adminis-
tration of erythromycin to Costa Rican patients 
caused significant decreases in faecal acetic, 
propionic, isobutyric, butyric, isovaleric, and 
valeric acid concentrations (Table 2). Cephalexin 
administration in Costa Rica also caused a signifi-
cant decrease in faecal butyric acid concentration 
and increase in isobutyric acid concentration. 
However, specimens obtained from the healthy par-
ticipants in Texas exhibited similar significant 
variations in concentrations of propionic and 
valeric acids from one collection period to another. 
There were no significant differences between the 
pH levels of specimens obtained from Texan or 
Costa Rican patients receiving antibiotics and from 
untreated healthy participants. Additionally, there 
were no significant differences in pH among speci-
mens from patients before, during, or after treat-
ment with any of the antibiotics included in the 
study (Table 3). 
DISCUSSION 
With the exception of erythromycin stearate, 
administered to Costa Rican patients, none of the 
antibiotics that were studied significantly altered 
total faecal VFA concentrations. We are unable to 
explain why erythromycin stearate produced an 
effect while erythromycin ethylsuccinate, that has 
the same antibacterial activity and bioavailability 
and is pharmacokinetically identical, did not. It is 
likely, however, that all variations in VFA concen-
trations that we observed were natural fluctuations 
and were not induced by antibiotic administration. 
Changes in individual VFA that occurred after 
erythromycin stearate administration were not sig-
nificantly different from changes occurring over 
time in healthy untreated participants from Texas. 
The results of our studies are similar to those 
obtained by Hoverstad et al.' who administered 
oral antibiotics to healthy adult volunteers and 
measured faecal VFA concentrations. Hoverstad 
and co-workers found that commonly used anti- 
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Table 1. Total VFA concentrations of faeces of children who received oral anti-
biotics and of untreated controls 
Antibiotics Total VFA 
First Specimen Second Specimen Third Specimen 
Untreated, Texas 
n =11 51.35 + 1424• 9260±24.67§ 31.39+ 	 3.26 
Treated, Texas Before During After 
Amoxicillin 
n =13 89.21 ± 11.98 109.11 + 22.84 78.61 ± 14.02 
Erythromycin 
n=14 70-36±11-64 
 
69.65 ± 24.36 97-12 + 34-35 
Penicillin 
n =3 104-85 ± 30.20 85.98± 19.61 111.78 + 	 4-54 
TMS 
n = 7 61.20± 12.61 55.58± 10-79 69.51 ± 12.81 
Treated, 
Costa Rica Before During After 
Ampicillin 
n =14 47.31 + 7.13 51.93 ± 10.54 49.26 + 5.42 
Cephalexin 
n=-13 62-83+ 10.77 54-67± 11.83 52-90+ 8-85 
Chloramphenicol 
n=6 35.98± 13-66 20.33± 4.43 50-15 + 10-09 
Dicloxacillin 
n = 11 68.20 + 16.62 83.59 ± 15.04 44-23 + 9-21 
Erythromycin 
n=11 72.00 ± 11.93 36-68 ± 5.88? 53.16+ 7.45 
TMS 
n= 14 56.05+ 5.62 53.55+ 	 8.11 65.62± 1042 
*Mean microequivalents acid per gram of faeces ± standard error of the mean. 
?Significantly lower value than either before of after treatment (p < 0.05). 
§Signific,antly greater value than third specimen (p <0-05). 
biotics that are absorbed from the intestine (eryth-
romycin, co-trimoxazol, doxycycline, nalidixic acid 
and ofloxacin) had little effect on VFA concen-
trations whereas non-absorbable antibiotics such as 
bacitracin and vancomycin significantly reduced 
concentrations of these acids. The antibiotics that 
we investigated are normally absorbed from the 
intestine. 
The findings in this study are in accord with our 
previous studies" which showed that orogastric 
administration of absorbable antibiotics to mice did 
not significantly alter caeca! VFA concentrations  
or, with the exception of chloramphenicol, influence 
caeca' pH levels. Colonisation resistance against S. 
typhimurium, S. flexneri or enterotoxigenic E. coli 
was not affected by administration of these anti-
biotics to mice, while a non-absorbable antibiotic, 
streptomycin, given to mice diminished caeca! VFA 
concentrations and reduced colonisation resistance 
to the above organisms. 
Examination of eight anatomical areas of the 
human gastrointestinal tract by Moore and 
Holdeman" revealed that the faecal flora is rep-
resentative of the fle,r1 of the ascending, transverse 
Table 2. Effects of selected oral antibiotics on faecal VFA concentrations 
Acetic Propionic lsobutyric Butyric Isovaleric Valerie 
Untreated 
Texas 
n=11 
First 
Second 
Third 
28.05± 7-16* 
39.56±13.40 
17.38± 	 1.94 
10-69+14.12 
28.781 9.91f 
6-98+ 0-70 
2.95±1.51 
4.47±2.05 
0-76+0-24 
7.14+2.68 
8.26±1.83 
43210.84 
1.25±0.43 
819+4-88 
1.18±0.46 
C/1 
1.39±0.30 
3.44+0.88f 
9.77+0-20 
Erythromycin Before 35.22± 3.95 14.99± 3-79 1.60±0.55 15-53+540 3.03±0.91 1.53 + 0.81 
Costa Rica During 24.09± 3.32* 6.911 1.24 0.42±0.24§ 6.84±2.25§ 0.41 +0-28§ 0§ 
n = 11 After 29.24± 3.30 15.59± 	 3.15 0.45±0.32 6.431142 0.99±0.44 0.27+0-19 
Cephalexin Before 36.22± 5-45 15.641 6.28 0 94011.81 0.9210-20 0.63±0.29 
Costa Rica During 33.64± 6.58 14-251 5.73 9.93±0.091' 5-39+1.24 0.87 ± 0.21 04310.23 
n = 13 After 28.00+ 5.02 14.43± 3-21 0.39+0.23 7-13 ± 0.95 2.24±0.54 0.66 ± 0.34 
•Mean microequivalents per gram of faeces ± standard error of the mean. 
tSignificantly greater value than before treatment (p <0-05). 
*Significantly lower value than before treatment ( p< 0-04 
0 
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Table 3. pH values of faeces of children who received oral antibiotics and of 
untreated controls 
Antibiotics PH 
First Specimen Second Specimen Third Specimen 
Untreated, Texas 
n = 11 6.56±0.37• 7.20 ± 0-29 7-03+0.24 
Treated, Texas Before During After 
Amoxicillin 
n = 13 6.93±0.28 6-78 + 0.25 6.94± 0.28 
Erythromycin 
n = 14 6.81 ±0.27 7.08 + 0.29 7.49+023 
Penicillin 
n = 3 6.78 +0-11 7-05 ± 0.38 6.86+0.23 
TMS 
n = 7 6.90+ 0.40 6.59 ±0.39 6.97+0-33 
Treated, 
Costa Rica Before During After 
Ampicillin 
n = 14 6.23+0.31 6.10 +0.32 6-00+0.34 
Cephalexin 
n =13 6.37+0-31 6'18±0.35 6-95+0.15 
Chloramphenicol 
n = 6 5.56+0.45 6.07+0.28 6-45+0-43 
Dicloxacillin 
n =11 6.10+0-34 6.63 + 0-23 6.67 +0.44 
Erythromycin 
n .= 11 5-91+0-33 6.22 ± 0-18 6.46±0.35 
TMS 
n = 14 6-35 + 0.29 6.05 + 0-28 5-84 + 0-27 
*Mean pH value of faeces ± standard error of the mean. 
and descending colon and rectum. These investi-
gators state that the feces should contain the 
bacterial populations or bacterial activities present 
in the colon. It is not unreasonable to assume, there-
fore, that the VFA concentrations in the human 
colon are similar to the concentrations present in 
the faeces and that these acids at physiological pH 
levels interfere with the colonisation of the human 
intestinal tract by enteric pathogens. 
Our study indicates that commonly administered 
non-absorbable antibiotics have little effect on 
human intestinal VFA concentrations or pH levels. 
We speculate, therefore, that their use does not 
compromise natural resistance against enteric  
pathogens mediated by VFA and hydrogen-ions in 
the human colon. 
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